HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ertapenem: review of a new carbapenem.

Abstract
The carbapenems are beta-lactam-type antibiotics with an exceptionally broad spectrum of activity. Ertapenem is a new carbapenem developed to address the pharmacokinetic shortcomings (short half-life) of imipenem and meropenem. Ertapenem shares similar structural features with meropenem, including its stability to dehydropeptidase-1, allowing it to be administered without a dehydropeptidase-1 inhibitor. Ertapenem, like imipenem and meropenem, demonstrates broad-spectrum antimicrobial activity against many Gram-positive and -negative aerobes and anaerobes and is resistant to nearly all beta-lactamases, including extended-spectrum beta-lactamases and AmpCs. However, it differs from both imipenem and meropenem in demonstrating limited activity against Enterococcusspp., Pseudomonasaeruginosa and other nonfermentative Gram-negative bacteria commonly associated with nosocomial infections. The extensive protein binding of ertapenem extends the half-life and allows for once-daily dosing. Prospective, multicenter, randomized, double-blind, comparative clinical studies demonstrate similar clinical efficacy of ertapenem compared with other agents. Clinical trials of complicated intra-abdominal infection, acute pelvic infection, complicated skin and soft-structure infection, community-acquired pneumonia and complicated urinary tract infections demonstrated that ertapenem has equivalent efficacy and safety compared with ceftriaxone and piperacillin/tazobactam. Ertapenem is a promising new carbapenem with excellent efficacy and safety for the treatment of a variety of community-acquired infections. It also appears to be of great value as an outpatient parenteral antimicrobial therapy.
AuthorsGeorge G Zhanel, Christel Johanson, John M Embil, Ayman Noreddin, Alfred Gin, Lavern Vercaigne, Daryl J Hoban
JournalExpert review of anti-infective therapy (Expert Rev Anti Infect Ther) Vol. 3 Issue 1 Pg. 23-39 (Feb 2005) ISSN: 1478-7210 [Print] England
PMID15757455 (Publication Type: Journal Article, Review)
Chemical References
  • Carbapenems
  • Drugs, Investigational
  • Lactams
  • beta-Lactams
  • Ertapenem
Topics
  • Animals
  • Carbapenems (chemistry, metabolism, therapeutic use)
  • Drugs, Investigational (adverse effects, chemistry, metabolism, therapeutic use)
  • Ertapenem
  • Humans
  • Lactams (chemistry, metabolism, therapeutic use)
  • beta-Lactams

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: